sunday 23 sEpTEMbEr - ehmtic 2012
sunday 23 sEpTEMbEr - ehmtic 2012
sunday 23 sEpTEMbEr - ehmtic 2012
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
56<br />
EHMTIC20I2<br />
European Headache and Migraine Trust International Congress<br />
Poster Programme<br />
contInued<br />
P176 Survey of the differences between Migraine and MOH pre-existing migraine<br />
Igarashi, H.<br />
Department of Internal Medicine Yokohama Dental and Medical Clinic Kanagawa Dental College, Japan<br />
P177 Grey matter changes in medication-overuse headache before and after medication withdrawal<br />
Riederer, F. 1 ; Gantenbein, A.R. 1 ; Marti, M. 1 ; Luechinger, R. 2 ; Kollias, S. 3 ; Sándor, P.S. 4<br />
1 University Hospital Zurich, Department of Neurology, Switzerland; 2 Institute for Biomedical Engineering, Swiss Federal Institute<br />
of Technology and the University of Zurich, Switzerland; 3 Institute of Neuroradiology, University Hospital Zurich, Switzerland;<br />
4 RehaClinic Bad Zurzach/Baden, Switzerland<br />
P178 Temperament and character profiles of patients with chronic migraine and medication-overuse headache<br />
Watanabe, Y.; Tateno, H.; Hirata, K.<br />
Dokkyo Medical University, Japan<br />
P179 DNIC in whiplash and ankle-injured controls. 1-year prospective findings<br />
Kasch, H.; Jensen, T.S.<br />
Danish Pain Research Center, Denmark<br />
P180 Treatment and outcome in medication overuse headache patients<br />
Mitsikostas, D.; Deligianni, I.<br />
Athens Naval Hospital, Greece<br />
P181 Occipital locked headache<br />
Whitehouse, A.; Momoh-Ojewuyi, A.; Abusamara, R.; Al-Ani, S.; Alkilani, R.; Ahmed, M.A.S.<br />
Barking Havering & Redbridge NHS Trust, United Kingdom<br />
10.30-12.00<br />
posTEr sEssIon g:<br />
MIgraInE THErapy: pHarMaCologICal aCuTE and prEvEnTaTIvE MIgraInE THErapy<br />
10.30-11.10 Poster viewing P182-P216, LB03, LB06 – Exhibition area<br />
11.10-11.20 Break<br />
11.20-12.00 Poster discussion – Kings Suite<br />
(selected posters will be presented and discussed)<br />
Authors of odd numbers (P183, P185, P187, etc) will attend their poster for the first 20 minutes of the poster<br />
viewing session (10.30-10.50). Authors of even numbered posters (P184, P186, P188,etc) will attend their poster<br />
for the second 20 minutes of the poster viewing session (10.50-11.10).<br />
P183 In vitro characterization of AA71, a potent and selective human monoclonal antibody against CGRP receptor<br />
Shi, L.; Rao, S.; Sun, H.; Wild, K.; Xu, C.<br />
Department of Neuroscience, Amgen, Inc. Thousand Oaks, California, United States<br />
P184 Prevention of migraine by supraorbital transcutaneous neurostimulation using the Cefaly® device<br />
(PREMICE): a multi-centre, randomized, sham-controlled trial<br />
Schoenen, J. 1 ; Vandersmissen, B. 2 ; Jeangette, S. 2 ; Herroelen, L. 2 ; Vandenheede, M. 2 ; Gerard, P. 1 ; Magis, D. 1<br />
1 2 Headache Research Unit, Belgium; Department of Neurology, Belgium<br />
P186 Review of 500 migraine cases treated with combination of antidepressant & CBT & specific group of dietary<br />
supplement with 6 month follow up<br />
Goyal, V.K.<br />
Parth Hospital, India
Change language